Stock News - Maze Therapeutics, Inc. $MAZE

Latest Stock News for $MAZE
Maze Therapeutics Reports Strong Q4 2025 Results and Appoints Neil Kumar to Board

Expected Stock impact: Noticeably Positive
2026-03-25 11:21:02